{
    "code": "02025095",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025095",
    "time": "2016-01-22 03:16:42",
    "許可證字號": "衛署藥輸字第025095號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/09\/23",
    "發證日期": "98\/09\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202509502",
    "中文品名": "博脈舒錠 16 毫克",
    "英文品名": "Blopress Tablets 16 mg",
    "適應症": "本態性高血壓。治療左心室射出分率≦ 40%之心臟衰竭病患，作為血管加壓素轉化&#37238;抑制劑(ACE-inhibitors)的輔助療法，或使用於無法耐受血管加壓素轉化&#37238;抑制劑(ACE-inhibitors)的病人，以減少心臟血管死亡率或心衰竭導致之住院。",
    "劑型": "110錠劑",
    "包裝": "2-1000 錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "CANDESARTAN CILEXETIL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1406701100  臺灣武田藥品工業股份有限公司",
    "申請商地址": "台北市南京東路三段２１７號７Ｆ",
    "主製造廠": {
        "製造廠名稱": "F260146000  KOKANDO CO. LTD.",
        "製造廠廠址": "NO 9-1, UMEZAWACHO, 2-CHOME TOYAMA CITY,JAPAN.",
        "製造廠公司地址": "",
        "製造廠國別": "JAPAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝及分裝"
        },
        {
            "製造廠名稱": "F260328300  TAKEDA PHARMACEUTICAL COMPANY LIMITED",
            "製造廠廠址": "1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA, JAPAN.",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005710",
            "成分名稱": "CANDESARTAN CILEXETIL",
            "含量描述": "",
            "含量": "16.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "03_中文仿單_Blopress 16mg Leaflet rev2-104-12-29.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=001&Type=9"
        }
    ]
}